A Feasbility Evaluating the Use of Home OCT for a Clinical Trial of Faricimab Treatment of nAMD
We discuss the feasibility of using home OCT vs. a treat and extend approach in a clinical trial of faricimab in neovascular AMD with Dr. Kevin Blinder of the Retina Institute in Saint Louis, Mo and Profesor of Ophthalmology at Washington University School of Medicine.